STVN logo

STVN
Stevanato Group Spa

184
Mkt Cap
$4.83B
Volume
725,840.00
52W High
$28.00
52W Low
$12.89
PE Ratio
30.51
STVN Fundamentals
Price
$17.79
Prev Close
$17.71
Open
$17.63
50D MA
$15.11
Beta
0.84
Avg. Volume
621,355.59
EPS (Annual)
$0.5782
P/B
2.78
$5,889.31
Loading...
Loading...
News
all
press releases
Stevanato Group to Participate in Three Upcoming Investor Conferences
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences: Tuesday, May 12, at 8:00...
Business Wire·6h ago
News Placeholder
More News
News Placeholder
Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out for
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·14h ago
News Placeholder
Stevanato Group S.p.A. (NYSE:STVN) Given Average Recommendation of "Hold" by Brokerages
Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have been assigned an average rating of "Hold" from the five ratings firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a...
MarketBeat·21h ago
News Placeholder
Jennison Associates LLC Buys 213,602 Shares of Stevanato Group S.p.A. $STVN
Jennison Associates LLC grew its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 13.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,772,896 shares of the company's stock after acquiring an...
MarketBeat·3d ago
News Placeholder
Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth
Stevanato (STVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·5d ago
News Placeholder
Stevanato Group (NYSE:STVN) Sees Unusually-High Trading Volume - Should You Buy?
Stevanato Group (NYSE:STVN) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat·5d ago
News Placeholder
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries...
Business Wire·11d ago
News Placeholder
Stevanato Group (NYSE:STVN) Trading 6.7% Higher - Time to Buy?
Stevanato Group (NYSE:STVN) Trading Up 6.7% - Still a Buy...
MarketBeat·11d ago
News Placeholder
Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Decrease in Short Interest
Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totaling...
MarketBeat·20d ago
News Placeholder
Stevanato Group (NYSE:STVN) Sees Strong Trading Volume - Still a Buy?
Stevanato Group (NYSE:STVN) Sees Strong Trading Volume - Time to Buy...
MarketBeat·20d ago
<
1
2
...
>

Latest STVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.